Ameet Nathwani

President and Chief Executive Officer at Dewpoint Therapeutics.

Raised on Dewpoint Therapeutics filings

$77.2M

of $82.3M offered across 1 Form D filing

Company

Biotech · Boston, MA

Small-molecule drugs that target biomolecular condensates

Small-molecule drugs that target biomolecular condensates

Dewpoint Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Jul 13, 2026	Equity	$77.2M/ $82.3M	Form D/A

Also named on Dewpoint Therapeutics filings